Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Demethoxycurcumin
Cat. No.:
OB0225LY-0402
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Demethoxycurcumin is an active active ingredient that exhibits antioxidant and anti-inflammatory properties.
Synonym:
Curcumin II; Desmethoxycurcumin; Monodemethoxycurcumin; 22608-11-3; 4-Hydroxycinnamoyl(feroyl)methane; (1E-,6E)-1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione; 1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-, (1E-,6E)-; p-Hydroxycinnamoyl-feruloylmethane
CAS No.:
22608-11-3
Compound CID:
5469424
Formula:
C20H18O5
Formula Weight:
338.35
Specification
Relative Density:
1.282 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Demethoxycurcumin can be used to study its important role in anti-tumor and anti-inflammatory mechanisms.
Library Information
Pathways:
Microbiology/Virology; Oxidation-reduction; Apoptosis; Autophagy
Plate Number:
AOCL-6
Plate Location:
b8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 147.78 mM
